Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders.

J Med Chem

Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn institution, An der Immenburg 4, Bonn 53121, Germany.

Published: January 2025

Targeted protein degradation (TPD) represents a promising alternative to conventional occupancy-driven protein inhibition. Despite the existence of more than 600 E3 ligases in the human proteome, so far only a few have been utilized for TPD of histone deacetylases (HDACs), which represent important epigenetic anticancer drug targets. In this study, we disclose the first-in-class Fem-1 homologue B (FEM1B)-recruiting HDAC degraders. A set of 12 proteolysis targeting chimeras (PROTACs) was synthesized using a solid-phase supported parallel synthesis approach utilizing a covalent FEM1B ligand as an E3 ligase warhead. The evaluation of the HDAC degradation efficiency revealed substantial HDAC1 degradation by the top-performing degrader (: = 85%; DC = 257 nM). Unlike our previously published cereblon-recruiting selective HDAC6 degrader, , which uses the same HDAC ligand, the FEM1B-based PROTACs achieved selective HDAC1-3 degradation. This unexpected change in the HDAC isoform degradation profile was accompanied by significant enhancement of the antiproliferative properties.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.4c02569DOI Listing

Publication Analysis

Top Keywords

degradation
5
development first-in-class
4
first-in-class fem1b-recruiting
4
fem1b-recruiting histone
4
histone deacetylase
4
deacetylase degraders
4
degraders targeted
4
targeted protein
4
protein degradation
4
degradation tpd
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!